Document is current
Any future updates will be listed below
-
Authors
Herzig, Markus https://orcid.org/0000-0003-4435-7944
vom Hove, Maike https://orcid.org/0000-0002-7952-1073
Bertsche, Astrid https://orcid.org/0000-0003-2832-0156
Lipek, Tobias https://orcid.org/0000-0001-9700-3563
Kiess, Wieland https://orcid.org/0000-0003-4118-9455
Bertsche, Thilo https://orcid.org/0000-0002-4930-6655
Prenzel, Freerk https://orcid.org/0000-0002-2838-593X
Neininger, Martina Patrizia https://orcid.org/0000-0002-5208-0888
-
Funding
Funding for this research was provided by:
Universität Leipzig
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 28 March 2025
First Online: 7 April 2025
Declarations
:
: This study was approved by the Ethics Committee at the Medical Faculty of Leipzig University (Reg. no: 050/22-ek). Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: A.B. reports grants from UCB Pharma GmbH and honoraria for speaking engagements from Biogen GmbH, Desitin Arzneimittel GmbH, Eisai GmbH, GW Pharma GmbH, Jazz Pharmaceuticals GmbH, Neuraxpharm GmbH, Shire/Takeda GmbH, UCB Pharma GmbH, and ViroPharma GmbH. F.P. reports personal fees from Sanofi Aventis, Allergopharma, Stallergenes Greer, Vertex Pharmaceuticals, Takeda Pharma, and ALK-Abelló. T.L. reports honoraria for speaking engagements from Sanofi-Aventis, Novartis, and Aimmun. All reported grants, fees and honoraria are not related to the content of the manuscript. The other authors declare they have no conflicts of interest.
